Vertex Therapeutics and CRISPR Therapeutics. 2015. Vertex and CRISPR Therapeutics establish collaboration to Use CRISPR-Cas9 gene editing technology to discover and develop new treatments for genetic diseases. Available at: http://crisprtx.com/news-events/press-releases_2015-26-10.php (accessed November4, 2015).
12.
Spark Therapeutics. 2015. Spark Therapeutics announces positive top-line results from pivotal Phase 3 trial of SPK-RPE65 for genetic blinding conditions. Available at: http://ir.sparktx.com/mobile.view?c=253900&v=203&d=1&id=2093863 (accessed November6, 2015).
YueY, PanX, HakimCH, et al.Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophydogs with adeno-associated virus. Hum Mol Genet, 2015; 24:5880–5890.
Wyss Institute. 2015. Removing 62 barriers to pig-to-human organ transplant in one fell swoop. Available at: http://wyss.harvard.edu/viewpressrelease/222 (accessed November6, 2015).
17.
U.S. National Academy of Sciences and U.S. National Academy of Medicine. 2015. Session II, gene editing technologies. Available at: https://vimeo.com/album/3615412/video/142675484 (accessed November6, 2015).